Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital

被引:42
作者
Shen, Yin Zhong [1 ]
Qi, Tang Kai [1 ]
Ma, Jian Xin [1 ]
Jiang, Xue Yan [1 ]
Wang, Jiang Rong [1 ]
Xu, Qing Nian [1 ]
Huang, Qin [1 ]
Liu, Xi Nian [1 ]
Sun, Hong Qing [1 ]
Lu, Hong Zhou [1 ]
机构
[1] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200433, Peoples R China
关键词
acquired immune deficiency syndrome; deep fungal infection; epidemiology; antimycotic chemotherapy;
D O I
10.1111/j.1439-0507.2007.01421.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Invasive fungal infections (IFIs) have become a major cause of morbidity and mortality among people with acquired immune deficiency syndrome (AIDS), however, little is known about the clinical features and prognosis of IFI in AIDS in China. This study aimed to characterise the clinical features and prognosis of IFI in AIDS patients in China. We retrospectively reviewed the records of all HIV-infected patients at a Chinese university hospital between December 2004 and May 2006. We identified 35 patients with IFI. IFIs included thrush, oesophageal candidiasis, fungal pneumonia, cryptococcosis, penicilliosis and fungaemia, 44.4% of IFIs occurred in the digestive tract, 71.8% of IFIs occurred in patients with CD4(+)T-lymphocyte counts < 100 cells mm(-3). Candida albicans accounted for 57.4% of fungal pathogens isolated. All the patients received both antiretroviral and antifungal therapy; 27 patients were cured and eight died. IFI is one of the most common opportunistic infections in AIDS patients in China. IFIs mainly occur in patients with low CD4(+)T-lymphocyte counts. The majority of IFIs occur in the digestive tract. The most common pathogen causing IFI is C. albicans. The mortality rate remains high although antiretroviral therapy and many newer antifungals are available in China.
引用
收藏
页码:475 / 480
页数:6
相关论文
共 13 条
[1]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[2]   Treating opportunistic infections among HIV-infected adults and adolescents: Recommendations from CDC, the national institutes of health, and the HIV medicine association/infectious diseases society of America [J].
Benson, CA ;
Kaplan, JE ;
Masur, H ;
Pau, A ;
Holmes, KK .
CLINICAL INFECTIOUS DISEASES, 2005, 40 :S131-S235
[3]   Cryptococcal meningitis [J].
Bicanic, T ;
Harrison, TS .
BRITISH MEDICAL BULLETIN, 2005, 72 (01) :99-118
[4]  
Cheng WK, 2003, ASIAN J WOMEN STUD, V9, P7
[5]   The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: A call for better disease recognition and evaluation of adjuncts to antifungal therapy [J].
Ecevit, IZ ;
Clancy, CJ ;
Schmalfuss, IM ;
Nguyen, MH .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (10) :1443-1447
[6]   Invasive fungal infections: a review of epidemiology and management options [J].
Enoch, D. A. ;
Ludlam, H. A. ;
Brown, N. M. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (07) :809-818
[7]  
Kwon-Chwag KJ, 1992, MED MYCOL, P397
[8]  
[李从荣 Li Congrong], 2002, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V12, P485
[9]   In vitro susceptibility of 137 Candida sp isolates from HIV positive patients to several antifungal drugs [J].
Magaldi, S ;
Mata, S ;
Hartung, C ;
Verde, G ;
Deibis, L ;
Roldán, Y ;
Marcano, C .
MYCOPATHOLOGIA, 2001, 149 (02) :63-68
[10]   Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States [J].
Ostrosky-Zeichner, L ;
Rex, JH ;
Pappas, PG ;
Hamill, RJ ;
Larsen, RA ;
Horowitz, HW ;
Powderly, WG ;
Hyslop, N ;
Kauffman, CA ;
Cleary, J ;
Mangino, JE ;
Lee, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3149-3154